A clinical study to assess the influence of Tongluo Recipe on patients in convalescent stage of ischemic stroke: a randomized controlled trial
- Conditions
- Ischemic stroke
- Registration Number
- ITMCTR2100004440
- Lead Sponsor
- Putuo Hospital, Shanghai University of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
1. Patients who accord with Western and traditional Chinese medicine diagnostic criteria for ischemic stroke;
2. Patients with early stage of convalescence that is from 2 weeks to 3 months after stroke onset;
3. Aged from 45-80 years;
4. Patients with first attack, or re-attack and the former stroke is basically recovery with no sequel;
5. Patients with NIHSS score 7-22;
6. Be volunteer to participate in clinical trial;
7. Sign the written informed consent form.
1. Patients with ischemic stroke induced by confirmed brain trauma, tumor, parasitosis, blood disease, heart disease, metabolic disorder, et al;
2. Patients with consciousness or language disorder affecting communication;
3. Patients with limbs activity disorder induced by joint and muscle damage affecting neurological examination;
4. Patients with severe disease including heart disease, hepatic disease, kidney disease, endocrine disease or hematopoietic disease, et al;
5. Pregnant and lactating women or mental patients;
6. Patients allergic to the ingredients contained in the Chinese medicine adopted in this clinical trial;
7. Patients participating in the other clinical trial at the same time.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method FMA;NIHSS;MoCA;inflammatory factor detection;MRI examination;
- Secondary Outcome Measures
Name Time Method BI;TCM symptom score;MMSE;serum lipid, hemorheology and HCY test;